# US 2020/0393459 A1 · Ceacam1 based point-of-care cancer diagnostic

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0393459 A1
- Document ID: US20200393459A1
- Status: Published application
- Kind: A1
- Application number: 16/883,298
- Filed: 2020-05-26
- Published: 2020-12-17
- Earliest claimed: 2007-11-05
- Inventors: Gal Markel
- Web page: https://patentgrep.com/patent/US20200393459A1

## CPC

- G01N 33/54388: {based on lateral flow}
- G01N 33/57565: {involving carcinoembryonic antigen [CEA]}
- G01N 2333/70596: Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present technology regards the utilization of CAECAM1 as a biomarker for cancer. In particular the present invention regards the detection and measurement of soluble CAECAM1 levels for the detection and diagnosis of melanoma.

## Claims

### Claim 1

A device for the point-of-care detection of soluble CAECAM1 in a biological sample, the device comprising an immunochromatographic strip for the point-of-care detection of CEACAM1 in a biological sample.

### Claim 2 (depends on 1)

The device of claim 1, wherein the biological sample is blood, blood serum, or urine.

### Claim 3 (depends on 1)

The device of claim 1, wherein said immunochromatographic strip comprises a porous matrix having a sample application zone, a reaction zone, and a capture zone in communication with each other, said porous matrix supporting the capilary movement of said biological sample.

### Claim 4 (depends on 3)

The device of claim 3, wherein the reaction zone comprises a mobile phase comprising a CEACAM1 specific antibody or fragment thereof conjugated to a detectable moiety

### Claim 5 (depends on 4)

The device of claim 4, wherein said detectable moiety comprises a radioactive isotope, an enzyme, a fluorescent dye, a dyed microsphere, an affinity tag, or any combination or derivative thereof.
